Neil R. Ackerman

1.2k total citations
34 papers, 912 citations indexed

About

Neil R. Ackerman is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, Neil R. Ackerman has authored 34 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pharmacology and 5 papers in Rheumatology. Recurrent topics in Neil R. Ackerman's work include Inflammatory mediators and NSAID effects (6 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Estrogen and related hormone effects (3 papers). Neil R. Ackerman is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Estrogen and related hormone effects (3 papers). Neil R. Ackerman collaborates with scholars based in United States, Poland and France. Neil R. Ackerman's co-authors include Russell O. Potts, James R. Beebe, Janet S. Kerr, W Galbraith, J A Tamada, H. Peter Chase, Saurabh K. Garg†, W. Schmidt, Richard J. Roman and Michael J. Tierney and has published in prestigious journals such as Nature, The Lancet and Diabetes Care.

In The Last Decade

Neil R. Ackerman

33 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil R. Ackerman United States 15 235 170 156 156 151 34 912
I. J. Zeitlin United Kingdom 20 246 1.0× 344 2.0× 42 0.3× 75 0.5× 70 0.5× 65 1.3k
S. L. Hempel United States 11 265 1.1× 401 2.4× 28 0.2× 73 0.5× 125 0.8× 17 1.2k
Stefano Persiani Italy 18 337 1.4× 274 1.6× 66 0.4× 53 0.3× 55 0.4× 55 1.2k
Kirti Patel India 21 167 0.7× 353 2.1× 89 0.6× 145 0.9× 49 0.3× 68 1.1k
Kiyoshi Yasui Japan 18 254 1.1× 205 1.2× 18 0.1× 210 1.3× 52 0.3× 41 1.1k
Dennis Argentieri United States 17 279 1.2× 225 1.3× 17 0.1× 280 1.8× 52 0.3× 25 896
Jennifer B. Frye United States 22 163 0.7× 410 2.4× 71 0.5× 35 0.2× 64 0.4× 49 1.6k
Kouichi Katayama Japan 19 77 0.3× 728 4.3× 46 0.3× 94 0.6× 111 0.7× 57 1.3k
Mario Pinza Italy 22 146 0.6× 426 2.5× 30 0.2× 280 1.8× 43 0.3× 69 1.4k
Bandana Chakravarti India 22 197 0.8× 647 3.8× 67 0.4× 273 1.8× 90 0.6× 41 1.3k

Countries citing papers authored by Neil R. Ackerman

Since Specialization
Citations

This map shows the geographic impact of Neil R. Ackerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil R. Ackerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil R. Ackerman more than expected).

Fields of papers citing papers by Neil R. Ackerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil R. Ackerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil R. Ackerman. The network helps show where Neil R. Ackerman may publish in the future.

Co-authorship network of co-authors of Neil R. Ackerman

This figure shows the co-authorship network connecting the top 25 collaborators of Neil R. Ackerman. A scholar is included among the top collaborators of Neil R. Ackerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil R. Ackerman. Neil R. Ackerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tierney, Michael J., Saurabh Garg, Neil R. Ackerman, et al.. (2000). Effect of Acetaminophen on the Accuracy of Glucose Measurements Obtained with the GlucoWatch Biographer. Diabetes Technology & Therapeutics. 2(2). 199–207. 12 indexed citations
2.
Tierney, Michael J., et al.. (2000). The GlucoWatch®biographer: a frequent, automatic and noninvasive glucose monitor. Annals of Medicine. 32(9). 632–641. 110 indexed citations
3.
Garg†, Saurabh K., et al.. (1999). Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.. Diabetes Care. 22(10). 1708–1714. 155 indexed citations
4.
Pratta, Michael A., Neil R. Ackerman, & Elizabeth C. Arner. (1998). Effect of ebselen on IL-1-induced alterations in cartilage metabolism. Inflammation Research. 47(3). 115–121. 10 indexed citations
5.
Neville, Mary E., et al.. (1990). In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1β. Cytokine. 2(6). 456–463. 19 indexed citations
6.
Galbraith, W, et al.. (1990). Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 180–187. 190 indexed citations
7.
Harris, Richard R., et al.. (1990). Cellular and Biochemical Characterization of the Anti-Inflammatory Effects of DuP 654 in the Arachidonic Acid Murine Skin Inflammation Model (Part 1 of 2). Skin Pharmacology and Physiology. 3(1). 29–34. 5 indexed citations
8.
Jaffee, Bruce, et al.. (1989). The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats. Inflammation Research. 27(3-4). 344–346. 32 indexed citations
9.
Harris, Richard R., Douglas G. Batt, W Galbraith, & Neil R. Ackerman. (1989). Topical anti-inflammatory activity of DuP 654, a 2-substituted 1-naphthol. Inflammation Research. 27(3-4). 297–299. 9 indexed citations
11.
Kerr, Janet S., et al.. (1988). Induction of Superoxide Dismutase Activity by Paraquat or Edu in Human Gingival Fibroblasts. PubMed. 49. 695–698. 2 indexed citations
12.
Boswell, George A., et al.. (1988). Induction of antioxidant enzyme activities by a phenylurea derivative, EDU. Toxicology and Applied Pharmacology. 96(1). 33–42. 21 indexed citations
13.
Arner, Elizabeth C., et al.. (1987). Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation. Inflammation Research. 21(3-4). 334–336. 16 indexed citations
14.
Kerr, Janet S., et al.. (1987). Acute lung inflammation in rats induced by phorbol myristate acetate (PMA). Inflammation Research. 21(3-4). 293–296. 8 indexed citations
15.
Ackerman, Neil R., et al.. (1982). Relationship between adherence, chemotaxis and the accumulation of rat polymorphonuclear leukocytes at an inflammatory site.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 701–707. 18 indexed citations
16.
Lipinski, Christopher A., et al.. (1980). Bronchodilator and antiulcer phenoxypyrimidinones. Journal of Medicinal Chemistry. 23(9). 1026–1031. 14 indexed citations
17.
Ackerman, Neil R., et al.. (1979). Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis & Rheumatism. 22(12). 1365–1374. 84 indexed citations
18.
Goodglass, Harold & Neil R. Ackerman. (1978). Selected papers in neurolinguistics. W. Fink eBooks. 1 indexed citations
19.
Ackerman, Neil R.. (1977). The lack of an effect of ?9-THC on pulmonary smooth muscle function in the guinea pig. Toxicology and Applied Pharmacology. 41(2). 321–328. 5 indexed citations
20.
Ackerman, Neil R. & Charles B. Metz. (1972). Effects of multiple antibody layers on Arbacia eggs. Experimental Cell Research. 72(1). 204–210. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026